Harte Hanks (HHS) Return on Invested Capital (2016 - 2025)
Harte Hanks (HHS) has disclosed Return on Invested Capital for 15 consecutive years, with 5.73% as the latest value for Q2 2025.
- On a quarterly basis, Return on Invested Capital changed N/A to 5.73% in Q2 2025 year-over-year; TTM through Jun 2025 was 5.73%, a N/A change, with the full-year FY2024 number at 0.08%, down 6.0% from a year prior.
- Return on Invested Capital was 5.73% for Q2 2025 at Harte Hanks, down from 0.98% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 9.54% in Q4 2022 to a low of 5.73% in Q2 2025.
- A 5-year average of 0.1% and a median of 0.38% in 2022 define the central range for Return on Invested Capital.
- Peak YoY movement for Return on Invested Capital: skyrocketed 968bps in 2022, then plummeted -994bps in 2023.
- Harte Hanks' Return on Invested Capital stood at 0.14% in 2021, then surged by 6930bps to 9.54% in 2022, then crashed by -104bps to 0.4% in 2023, then crashed by -146bps to 0.98% in 2024, then tumbled by -483bps to 5.73% in 2025.
- Per Business Quant, the three most recent readings for HHS's Return on Invested Capital are 5.73% (Q2 2025), 0.98% (Q4 2024), and 0.07% (Q3 2024).